COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES
CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its plant-derived, Type I recombinant human collagen (rhCollagen) for tissue regeneration and medical...